These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26401591)

  • 1. Aldosterone Impairs Vascular Smooth Muscle Function: From Clinical to Bench Research.
    Chou CH; Chen YH; Hung CS; Chang YY; Tzeng YL; Wu XM; Wu VC; Tsai CT; Wu CK; Ho YL; Wu KD; Lin YH;
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4339-47. PubMed ID: 26401591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis.
    Wu VC; Lo SC; Chen YL; Huang PH; Tsai CT; Liang CJ; Kuo CC; Kuo YS; Lee BC; Wu EL; Lin YH; Sun YY; Lin SL; Chen JW; Lin SJ; Wu KD;
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3175-83. PubMed ID: 21816781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparison of Adrenalectomy and Eplerenone on Vascular Function in Patients with Aldosterone-producing Adenoma.
    Kishimoto S; Oki K; Maruhashi T; Kajikawa M; Hashimoto H; Takaeko Y; Harada T; Yamaji T; Han Y; Kihara Y; Chayama K; Goto C; Yusoff FM; Nakashima A; Higashi Y
    J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32818224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism.
    Nishizaka MK; Zaman MA; Green SA; Renfroe KY; Calhoun DA
    Circulation; 2004 Jun; 109(23):2857-61. PubMed ID: 15173035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aldosterone-producing adenoma on endothelial function and Rho-associated kinase activity in patients with primary aldosteronism.
    Matsumoto T; Oki K; Kajikawa M; Nakashima A; Maruhashi T; Iwamoto Y; Iwamoto A; Oda N; Hidaka T; Kihara Y; Kohno N; Chayama K; Goto C; Aibara Y; Noma K; Liao JK; Higashi Y
    Hypertension; 2015 Apr; 65(4):841-8. PubMed ID: 25624340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal sympathetic vasomotor and cardiac parasympathetic activities in patients with primary aldosteronism: assessment by spectral analysis.
    Munakata M; Imai Y; Hashimoto J; Omata K; Nakao M; Yamamoto M; Abe K
    J Auton Nerv Syst; 1995 Apr; 52(2-3):213-23. PubMed ID: 7615899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism.
    Lin YH; Wu XM; Lee HH; Lee JK; Liu YC; Chang HW; Lin CY; Wu VC; Chueh SC; Lin LC; Lo MT; Ho YL; Wu KD;
    J Hypertens; 2012 Aug; 30(8):1606-13. PubMed ID: 22688266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy.
    Lenzini L; Prisco S; Vanderriele PE; Lerco S; Torresan F; Maiolino G; Seccia TM; Iacobone M; Rossi GP
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3726-3734. PubMed ID: 30865228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy.
    Lin YH; Lee HH; Liu KL; Lee JK; Shih SR; Chueh SC; Lin WC; Lin LC; Lin LY; Chung SD; Wu VC; Kuo CC; Ho YL; Chen MF; Wu KD;
    Surgery; 2011 Sep; 150(3):526-33. PubMed ID: 21514614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.
    ; Wu VC; Chueh SC; Chang HW; Lin LY; Liu KL; Lin YH; Ho YL; Lin WC; Wang SM; Huang KH; Hung KY; Kao TW; Lin SL; Yen RF; Chen YM; Hsieh BS; Wu KD
    Am J Kidney Dis; 2009 Oct; 54(4):665-73. PubMed ID: 19628318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
    Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
    Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone suppression on contralateral adrenal during adrenal vein sampling does not predict blood pressure response after adrenalectomy.
    Monticone S; Satoh F; Viola A; Fischer E; Vonend O; Bernini G; Lucatello B; Quinkler M; Ronconi V; Morimoto R; Kudo M; Degenhart C; Gao X; Carrara D; Willenberg HS; Rossato D; Mengozzi G; Riester A; Paci E; Iwakura Y; Burrello J; Maccario M; Giacchetti G; Veglio F; Ito S; Reincke M; Mulatero P
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4158-66. PubMed ID: 25119314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unilateral adrenalectomy improves urinary protein excretion but does not abolish its relationship to sodium excretion in patients with aldosterone-producing adenoma.
    Pimenta E; Gordon RD; Ahmed AH; Cowley D; Robson D; Kogovsek C; Stowasser M
    J Hum Hypertens; 2011 Oct; 25(10):592-9. PubMed ID: 21068764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe obesity is associated with impaired arterial smooth muscle function in young adults.
    Ayer JG; Harmer JA; David C; S Steinbeck K; Seale JP; Celermajer DS
    Obesity (Silver Spring); 2011 Jan; 19(1):54-60. PubMed ID: 20489689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impacts of endothelium-dependent flow-mediated vasodilation assessment on primary aldosteronism.
    Watanabe D; Morimoto S; Morishima N; Ichihara A
    Endocr Connect; 2021 Jun; 10(6):578-587. PubMed ID: 33984834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases.
    Iwakura Y; Morimoto R; Kudo M; Ono Y; Takase K; Seiji K; Arai Y; Nakamura Y; Sasano H; Ito S; Satoh F
    J Clin Endocrinol Metab; 2014 May; 99(5):1593-8. PubMed ID: 24285678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone excess impairs first phase insulin secretion in primary aldosteronism.
    Fischer E; Adolf C; Pallauf A; Then C; Bidlingmaier M; Beuschlein F; Seissler J; Reincke M
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2513-20. PubMed ID: 23539730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delineating the receptor mechanisms underlying the rapid vascular contractile effects of aldosterone and estradiol.
    Gros R; Ding Q; Davis M; Shaikh R; Liu B; Chorazyczewski J; Pickering JG; Feldman RD
    Can J Physiol Pharmacol; 2011 Sep; 89(9):655-63. PubMed ID: 21854125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospitalized acute exacerbation of COPD impairs flow and nitroglycerin-mediated peripheral vascular dilation.
    Marchetti N; Ciccolella DE; Jacobs MR; Crookshank A; Gaughan JP; Kashem MA; Bove AA; Criner GJ
    COPD; 2011 Apr; 8(2):60-5. PubMed ID: 21495833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.